Bigotry is abound, apprently, within these boards. There is a level of supposed tolerance I will have no part of. Obviously, it seems to be well-embraced here. I have finally found something more fucked up than what I'm used to. Congrats. - Ruby
This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.
Paradoxically the hottest fields, with the most people pursuing the same questions, are most prone to error, Dr. Ioannidis argued. If one of five competing labs is alone in finding an effect, that result is the one likely to be published. But there is a four in five chance that it is wrong. Papers reporting negative conclusions are more easily ignored.
Putting all of this together, Dr. Ioannidis devised a mathematical model supporting the conclusion that most published findings are probably incorrect.
Other scientists have questioned whether his methodology was skewed by his own biases. But the same year he published another blockbuster, examining more than a decade’s worth of highly regarded papers — the effect of a daily aspirin on cardiac disease, for example, or the risks of hormone replacement therapy for older women. He found that a large proportion of the conclusions were undermined or contradicted by later studies.
His work was just the beginning. Concern about the problem has reached the point that the journal Nature has assembled an archive, filled with reports and analyses, called Challenges in Irreproducible Research.
Among them is a paper in which C. Glenn Begley, who is chief scientific officer at TetraLogic Pharmaceuticals, described an experience he had while at Amgen, another drug company. He and his colleagues could not replicate 47 of 53 landmark papers about cancer. Some of the results could not be reproduced even with the help of the original scientists working in their own labs.
Only one week into Colorado’s history-making recreational marijuana industry, one shop has already sold out of pot, others fear they may soon join it and perhaps as many as 100,000 people have legally purchased marijuana at Colorado stores.
Industry advocates estimate Colorado stores have already done more than $5 million in sales — including $1 million on New Year’s Day — though National Cannabis Industry Association executive director Aaron Smith acknowledges those are “back-of-the-envelope” figures. The owner of one store said she expects to make as much in sales in the first 10 days of January as she did all of last year selling medical marijuana.
“I had a dream once that I opened my store and didn’t have any competition,” said Robin Hackett, a co-owner of BotanaCare in Northglenn. “I had no idea it was a nightmare.”
Fears of marijuana shortages pervade the young industry. On Wednesday, a sign hung in the door to The Clinic location near Colorado Boulevard and Interstate 25 in Denver: “We are currently out of recreational cannabis. Please check back tomorrow. Sorry for the inconvenience.”
Many shops have imposed caps on maximum purchase amounts well below the caps required under state law. Numerous store owners say they have sold out of marijuana-infused edible products. Toni Fox, the owner of 3D Cannabis Center in Denver, said she closed her store down on Monday and Tuesday this week, just to restock and give her staff a rest.
Even for stores that reported robust inventory, like High Country Healing in Silverthorne, owners said marijuana could become scarce across the industry if more stores don’t get their licenses approved and open to absorb the flood of interest.